Jun 29, 2021 / 04:00PM GMT
Operator
Good afternoon, and welcome to the SCYNEXIS Conference Call. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the SCYNEXIS' website following the conclusion of the event. I would now like to turn the call over to Irina Koffler of LifeSci Advisors. You may being.
Irina Koffler - LifeSci Advisors, LLC - MD
Good afternoon, and thank you for joining us as we provide a corporate update on the pending BREXAFEMME launch for the treatment of VVC. Joining me today from SCYNEXIS are Dr. Marco Taglietti, President and Chief Executive Officer; Dr. Michael Krychman, Health Science, Clinical Professor at the University of California Irvine, Division of Gynecological Oncology; Christine Coyne, Chief Commercial Officer; and Eric Francois, Chief Financial Officer.
During this call, please note, we will be making forward-looking statements. These statements are subject to factors, risks and uncertainties, including those that are detailed in today's presentation and our Form 10-K for the year ended December 31,
SCYNEXIS Inc Corporate Commercial Launch Update Corporate Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot